Efficacy of Twice Daily Applications of LEO 124249 Ointment 30mg/g for 12 Weeks to Subjects With Alopecia Areata
Phase of Trial: Phase II
Latest Information Update: 05 Dec 2017
At a glance
- Drugs LEO 124249 (Primary)
- Indications Alopecia areata
- Focus Therapeutic Use
- Sponsors LEO Pharma
- 15 Dec 2016 Status changed from recruiting to completed.
- 04 Feb 2016 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
- 30 Sep 2015 New trial record